DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Endroit courant :
>
> This Story


Ouverture ou Registre to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Molecular Imaging Homepage

Mobile PET relieves hardship for rural cancer patients Mobile PET isn't just good medicine, it's good business

In nuclear medicine, scanners get more sensitive, software more specific What's new in PET and SPECT?

US suppliers to join the Mo-99 market, high-energy materials gaining traction Radiopharmaceutical supply chain update

Navigating the molecular imaging market Purchasing insights from the experts at MD Buyline

Absolute Imaging Solutions acquires Northeast Electronics Facilitates push into East Coast market

Assessing the state of Alzheimer’s imaging The battle against neuro-degenerative disease wages on

Eden Radioisotopes scores funding for isotope reactor production Will primarily produce Mo-99

SHINE secures rights to new method for Lutetium-177 production Generate Lu-177 at greater speed and scale

FDA gives green light to new United Imaging PET/MR scanner The uPMR 790 HD TOF performs total-body scans within 20 minutes

FDA reminder for properly eluting rubidium 82 generators prompted by 'recent incidents' Using incorrect solutions puts patients at risk

Rhodotron TT300 HE electron
beam accelerators

NorthStar buys IBA electron accelerators for Mo-99 production

par John R. Fischer , Staff Reporter
NorthStar Medical Radioisotopes has put forth downpayments for two Rhodotron TT300 HE electron beam accelerators produced by Ion Beam Applications (IBA).

The purchase and installation of the systems will enable the Wisconsin-based nuclear medicine enterprise to increase its production capacity and efficiencies, and create manufacturing redundancies that secure its supply of non-uranium-based, molybdenum-99 (Mo-99) radioisotopes for U.S. customers and patients.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



“The electron accelerators offer advantages in being one of the most effective methods of producing Mo-99, in addition to providing customized flexibility to accommodate customer needs, and production redundancies to minimize risks to customer supply,” Stephen Merrick, president and chief executive officer of NorthStar, told HCB News. “Adding accelerator production is one aspect of NorthStar's carefully staged approach to providing and expanding capacity for Mo-99 production in the United States.”

The machines will assist NorthStar in combating shortages of Mo-99, which will then be converted by the company’s RadioGenix system into technetium-99m (Tc-99m) for use in diagnostic imaging exams, such as for heart disease, cancer, infection, and inflammation, among other conditions. They also will be used in the production of new radiopharmaceuticals for diagnosis and treatment.

Each costing more than $6.7 million, the two will be installed in a 10,000-sq. ft. facility expansion, the groundbreaking of which is planned to take place in the next year in Beloit, Wisconsin. Construction will run parallel to the manufacturing of the accelerators and other equipment provided by IBA.

The installations build upon a number of milestones achieved by NorthStar over the past year, including the FDA clearance and first order of its RadioGenex System.

“Upon installation, which is expected in 2020, the facility and equipment will require appropriate validations, licensing and FDA approval(s) prior to use,” said Merrick. “Our ramp-up production capacity plans are underway to consistently meet more than 2/3 of market demand, and surge capacity would eventually provide the potential to meet total market demand.”

The need for domestic supplies of Mo-99 in the U.S. is a topic of great concern in the nuclear medicine world and one that recently pushed the Department of Energy to open up negotiations for potential new cooperative agreement awards with NorthStar and three other companies, to facilitate production of non-uranium-based Mo-99. NorthStar is the first domestic source of Mo-99 in nearly 30 years for the U.S.

The company plans to acquire and install six more Rhodotron systems from IBA in the coming years.

Operations at the new facility are expected to begin in 2021.

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

La publicité d'email
Développez la notoriété de votre marque
Enchères + Ventes Privées
Obtenir le meilleur prix
Acheter des équipement / pièces
Trouver le meilleur prix
Infos du jour
Lire Les dernières nouvelles
Annuaire
Consulter tous les utilisateurs DOTmed
Éthique concernant DOTmed
Voir notre programme d'éthique
L'or partie le programme de fournisseur
Recevoir des demandes PH
Programme de marchand de service d'or
Recevoir des demandes
Fournisseurs de soins de santé
Voir tous les outils des HCP (abréviation pour les professionnels de la santé)
Jobs/Formation
Trouver / combler un poste
Parts Hunter +EasyPay
Obtenir des devis de pièces
Voir les utilisateurs récemment certifiés
Voir les utilisateurs récemment certifiés
Récemment évalué sur DOTmed
Voir les utilisateurs récemment certifiés
Central de location
Louer de l’équipement à moindre prix
Vendre des équipements / pièces
Obtenir le maximum d'argent
Service Technicians Forum
Trouver de l'aide et des conseils
Simple demande de propositions
Obtenir des devis pour des appareils
Expo Virtuelle
Trouver des services d'appareils
L'Access et l'utilisation de cet emplacement est sujet aux modalités et aux conditions du notre de nos MENTIONS LEGALES & DONNEES PERSONELLES
Propriété de et classe des propriétaires DOTmedà .com, inc. Copyright ©2001-2019 DOTmed.com, Inc.
TOUS DROITS RÉSERVÉS